TREM2 and Alzheimer disease: Inactivating mutations in TREM2 are known to increase the risk of AD in humans [20, 21, 54], and AD mice deficient in Trem2 demonstrate an exacerbated AD pathology and increased neuroinflammation at older ages [23].